What is Jeffrey Klein?
HK Dermatology operates as a premier medical facility specializing in comprehensive dermatologic and cosmetic care. The practice is distinguished by the pioneering work of Dr. Jeffrey Klein, particularly his development of the tumescent liposuction technique, which has set a high standard for patient safety and recovery efficiency. The clinic provides a robust suite of services ranging from the treatment of complex skin conditions like skin cancer, acne, and eczema to advanced aesthetic procedures including Botox, dermal fillers, and laser-based interventions. By integrating both in-office consultations and virtual care options, the practice maintains a patient-centric approach that prioritizes accessibility, comfort, and clinical excellence in a rapidly evolving healthcare landscape.
How much funding has Jeffrey Klein raised?
Jeffrey Klein has raised a total of $374K across 2 funding rounds:
Debt
$150K
Debt
$224K
Debt (2020): $150K with participation from PPP
Debt (2021): $224K led by PPP
Key Investors in Jeffrey Klein
PPP
Public-Private Partnership
What's next for Jeffrey Klein?
With the recent influx of capital, HK Dermatology is poised to enter a new phase of growth, focusing on the modernization of its clinical infrastructure and the potential scaling of its proprietary treatment methodologies. The strategic allocation of these funds will likely support the adoption of next-generation medical technologies and the expansion of its specialized service offerings. As the practice navigates this late-stage development cycle, the focus remains on maintaining high-quality patient outcomes while optimizing operational workflows to meet the increasing demand for advanced dermatological solutions. This financial milestone serves as a testament to the practice's enduring value proposition and its commitment to innovation in the field of cosmetic and medical dermatology.
See full Jeffrey Klein company page
